Stocks to Watch: Sensex Expiry, Tata Steel, Cipla, HUDCO, Meesho in Focus Today

• Sensex weekly expiry today may cause sharp market fluctuations; Gift Nifty indicates a red start for domestic markets.
• Tata Steel's Q3 Indian production rose 11.4%, delivery volume jumped 14.2% YoY.
• Gland Pharma received US FDA approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC).
• HUDCO signed a non-binding MoU with Chhattisgarh government for up to ₹1 lakh crore financial assistance for housing and infrastructure projects.
• Cipla's supplier facility (Pharmathen International SA, Greece) received 9 observations on Form 483 from US FDA.

Why It Matters: Sensex expiry, corporate results, FDA approvals, and strategic deals to drive stock movements today.